Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled levodopa dry powder for recovery from off periods in Parkinson's disease
2017-004006-18Phase 2Active
- Sponsor
- University of Groningen
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of levodopa in Parkinson's disease (PD) (2 arms), sponsored by University of Groningen. Primary endpoint: Time until maximum motor effect. Started Nov 2017; status: active.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2017-004006-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004006-18.